(Q37811626)

23 August 2017

title

Vasoactive drugs in circulatory shock (English)

1 reference

23 August 2017

Steven M Hollenberg

1

1 reference

23 August 2017

language of work or name

English

0 references

publication date

19 November 2010

1 reference

American Journal of Respiratory and Critical Care Medicine

23 August 2017

published in

1 reference

23 August 2017

volume

183

1 reference

23 August 2017

issue

7

1 reference

23 August 2017

page(s)

847-855

1 reference

Fluid challenge revisited

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Microcirculatory oxygenation and shunting in sepsis and shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Bench-to-bedside review: Cytopathic hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Relation between muscle Na+K+ ATPase activity and raised lactate concentrations in septic shock: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Serum lactate as a predictor of mortality in patients with infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Early goal-directed therapy in the treatment of severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Continuous central venous and pulmonary artery oxygen saturation monitoring in the critically ill.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Microvascular alterations in patients with acute severe heart failure and cardiogenic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Early increases in microcirculatory perfusion during protocol-directed resuscitation are associated with reduced multi-organ failure at 24 h in patients with sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Sublingual capnometry tracks microcirculatory changes in septic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Hemodynamic monitoring in shock and implications for management. International Consensus Conference, Paris, France, 27-28 April 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Effects of perfusion pressure on tissue perfusion in septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Increasing mean arterial pressure in patients with septic shock: effects on oxygen variables and renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Septic shock: a goal-directed therapy using volume loading, dobutamine and/or norepinephrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Effect of dopamine vs norepinephrine on hemodynamics in septic shock. Emphasis on right ventricular performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

The effects of norepinephrine on hemodynamics and renal function in severe septic shock states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Norepinephrine or dopamine for the treatment of hyperdynamic septic shock?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Effect of norepinephrine on the outcome of septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Comparison of Dopamine and Norepinephrine in the Treatment of Shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Dobutamine improves gastrointestinal mucosal blood flow in a porcine model of endotoxic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Effects of dopamine and norepinephrine on systemic and hepatosplanchnic hemodynamics, oxygen exchange, and energy balance in vasoplegic septic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Anterior pituitary function during critical illness and dopamine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Dopamine affects cellular immune functions during polymicrobial sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Adrenaline in treatment of septic shock: effects on haemodynamics and oxygen transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Effects of epinephrine on right ventricular function in patients with severe septic shock and right ventricular failure: a preliminary descriptive study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

The effects of dopamine and adrenaline infusions on acid-base balance and systemic haemodynamics in severe infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Epinephrine impairs splanchnic perfusion in septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Epinephrine induces tissue perfusion deficit in porcine endotoxin shock: evaluation by regional CO(2) content gradients and lactate-to-pyruvate ratios

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Dopexamine and norepinephrine versus epinephrine on gastric perfusion in patients with septic shock: a randomized study [NCT00134212].

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

A comparison of epinephrine and norepinephrine in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

The evidence for small-volume resuscitation with hyperoncotic albumin in critical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Physiology of vasopressin relevant to management of septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Clinical practice. Preventing nephropathy induced by contrast medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Depletion of neurohypophyseal content of vasopressin in septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Circulating vasopressin levels in septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Beneficial effects of short-term vasopressin infusion during severe septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

High-dose vasopressin is not superior to norepinephrine in septic shock*

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Vasopressin versus norepinephrine infusion in patients with septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Profound but reversible myocardial depression in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Elevation of systemic oxygen delivery in the treatment of critically ill patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Cardiogenic shock after primary percutaneous coronary intervention: Effects of levosimendan compared with dobutamine on haemodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201006-0972CI

10.1164/RCCM.201006-0972CI

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference